Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN2B4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,036
Award facts
- Contract value 100% obligated
- $60,036.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $60,036.42 on February 4, 2026, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract utilizes firm fixed-price pricing and is not set-aside for any specific business category, indicating competitive award based on open competition. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor supporting federal medical procurement needs.
This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC vehicle enables the contractor to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications for diabetes, neurological conditions, pain management, and other therapeutic domains. The arrangement supports essential medical supply requirements for military treatment facilities, the Defense Health Agency, and other federal healthcare systems, demonstrating the contractor's significant role in the defense pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FN2B4?
SPE2DR26FN2B4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FN2B4 worth?
The government has obligated $60,036 on SPE2DR26FN2B4.
Is contract SPE2DR26FN2B4 an order under another contract?
Yes. SPE2DR26FN2B4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN2B4 competed?
The extent of competition for SPE2DR26FN2B4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award